Jingjing Ge

发表

Apatinib Plus Temozolomide: An Effective Salvage Treatment for Recurrent Glioblastoma

F. Xue, Chunjiang Yu, Cheng Li, 2021, Frontiers in Oncology.

The prognostic nutritional index, an independent predictor of overall survival for newly diagnosed follicular lymphoma in China

Yaxin Lei, Xiao-yan Feng, Mingzhi Zhang, 2022, Frontiers in Nutrition.

Establishment and validation of a prognostic nomogram for postoperative patients with gastric cardia adenocarcinoma: A study based on the Surveillance, Epidemiology, and End Results database and a Chinese cohort

Lei Wang, Y.Y. Qin, Ze-kang Wang, 2023, Cancer medicine.

Real-world evidence of ABVD-like regimens compared with ABVD in classical Hodgkin lymphoma: a 10-year study from China

Yaxin Lei, Mingzhi Zhang, Xudong Zhang, 2022, Journal of Cancer Research and Clinical Oncology.

Clinical expression and prognosis of SUV39H1 in diffuse large B-cell lymphoma

Xiaoyan Kong, Xudong Zhang, Wencai Li, 2021 .

SUV39H1 is a prognosis and immune microenvironment-related biomarker in diffuse large B-cell lymphoma

Yaxin Lei, Guan-nan Wang, Xudong Zhang, 2023, Clinical and Translational Oncology.

Combining therapy with recombinant human endostatin and cytotoxic agents for recurrent disseminated glioblastoma: a retrospective study

F. Xue, Jun-ping Zhang, Jing-jing Ge, 2019, BMC Cancer.

Long-Term Remission of Recurrent Brainstem Pilocytic Astrocytoma with Neuraxis Dissemination Using Recombinant Human Endostatin After Failure of Vincristine and Carboplatin.

Jun-ping Zhang, Jing-jing Ge, Cheng Li, 2018, World neurosurgery.

Clinical value of serum HMGB1 in diagnosis and prognosis of laryngeal squamous cell carcinoma

Yunhui Li, Zheng Liu, Guangbin Qiu, 2014, Medical Oncology.

Real-world evidence of ABVD-like regimens compared with ABVD in classical Hodgkin lymphoma: a 10-year study from China

Yaxin Lei, Xudong Zhang, M. Dong, 2022, Journal of Cancer Research and Clinical Oncology.